Jeff Auxier's ABBV Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 31,197 shares of AbbVie Inc. (ABBV) worth $7.13 M, representing 1.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Jeff Auxier has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 7,152 shares. Largest reduction occurred in Q3 2014, reducing 46,050 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Jeff Auxier
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -293 | Reduce 0.93% | 31,197 | $228.49 |
| Q3 2025 | -1,326 | Reduce 4.04% | 31,490 | $231.54 |
| Q2 2025 | -190 | Reduce 0.58% | 32,816 | $185.62 |
| Q1 2025 | +800 | Add 2.48% | 33,006 | $209.52 |
| Q4 2024 | -1,233 | Reduce 3.69% | 32,206 | $177.70 |
| Q3 2024 | -250 | Reduce 0.74% | 33,439 | $197.48 |
| Q1 2024 | -1,713 | Reduce 4.84% | 33,689 | $182.10 |
| Q4 2023 | -833 | Reduce 2.30% | 35,402 | $154.97 |
| Q3 2023 | -1,040 | Reduce 2.79% | 36,235 | $149.06 |
| Q2 2023 | +2,384 | Add 6.83% | 37,275 | $134.73 |
| Q1 2023 | -407 | Reduce 1.15% | 34,891 | $159.37 |
| Q4 2022 | -90 | Reduce 0.25% | 35,298 | $161.61 |
| Q3 2022 | -250 | Reduce 0.70% | 35,388 | $134.20 |
| Q2 2022 | -55 | Reduce 0.15% | 35,638 | $153.15 |
| Q1 2022 | -34 | Reduce 0.10% | 35,693 | $162.10 |
| Q4 2021 | -126 | Reduce 0.35% | 35,727 | $135.39 |
| Q3 2021 | -179 | Reduce 0.50% | 35,853 | $107.86 |
| Q2 2021 | -300 | Reduce 0.83% | 36,032 | $112.65 |
| Q1 2021 | -850 | Reduce 2.29% | 36,332 | $108.22 |
| Q4 2020 | +620 | Add 1.70% | 37,182 | $107.15 |
| Q3 2020 | +1,020 | Add 2.87% | 36,562 | $87.58 |
| Q2 2020 | +7,152 | Add 25.19% | 35,542 | $98.19 |
| Q1 2020 | -120 | Reduce 0.42% | 28,390 | $76.19 |
| Q4 2019 | -150 | Reduce 0.52% | 28,510 | $88.53 |
| Q3 2019 | +10 | Add 0.03% | 28,660 | $75.72 |
| Q2 2019 | +1,150 | Add 4.18% | 28,650 | $72.71 |
| Q1 2019 | +825 | Add 3.09% | 27,500 | $80.58 |
| Q4 2018 | -100 | Reduce 0.37% | 26,675 | $92.18 |
| Q3 2018 | +4,200 | Add 18.60% | 26,775 | $94.57 |
| Q2 2018 | -50 | Reduce 0.22% | 22,575 | $92.67 |
| Q1 2018 | -100 | Reduce 0.44% | 22,625 | $94.63 |
| Q4 2017 | -50 | Reduce 0.22% | 22,725 | $96.72 |
| Q3 2017 | -50 | Reduce 0.22% | 22,775 | $88.87 |
| Q1 2017 | +2,000 | Add 9.60% | 22,825 | $65.15 |
| Q4 2016 | +203 | Add 0.98% | 20,825 | $62.62 |
| Q3 2016 | -50 | Reduce 0.24% | 20,622 | $63.09 |
| Q2 2016 | +100 | Add 0.49% | 20,672 | $61.92 |
| Q1 2016 | +300 | Add 1.48% | 20,572 | $57.12 |
| Q3 2015 | +1,101 | Add 5.74% | 20,272 | $54.41 |
| Q1 2015 | -7,900 | Reduce 29.18% | 19,171 | $58.53 |
| Q4 2014 | -300 | Reduce 1.10% | 27,071 | $65.46 |
| Q3 2014 | -46,050 | Reduce 62.72% | 27,371 | $57.76 |
| Q2 2014 | -5,019 | Reduce 6.40% | 73,421 | $56.44 |
| Q4 2013 | -2,000 | Reduce 2.49% | 78,440 | $52.80 |
| Q2 2013 | +80,441 | Add 0.00% | 80,440 | $41.34 |
Jeff Auxier's AbbVie Investment FAQs
Jeff Auxier first purchased AbbVie Inc. (ABBV) in Q2 2013, acquiring 80,440 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held AbbVie Inc. (ABBV) for 51 quarters since Q2 2013.
Jeff Auxier's largest addition to AbbVie Inc. (ABBV) was in Q2 2013, adding 80,440 shares worth $3.32 M.
According to the latest 13F filing for Q4 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 31,197 shares of AbbVie Inc. (ABBV), valued at approximately $7.13 M.
As of the Q4 2025 filing, AbbVie Inc. (ABBV) represents approximately 1.00% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings.
Jeff Auxier's peak holding in AbbVie Inc. (ABBV) was 80,440 shares, as reported at the end of Q2 2013.